Ngoc Ha Nguyen | Genetics and Molecular Biology | Academic Excellence Citation Award

Published on by Citation Awards

Academic Excellence Citation Award

Ngoc Ha Nguyen
Ho Chi Minh City University of Medicine and Pharmacy, Vietnam

Ngoc Ha Nguyen
Affiliation Ho Chi Minh City University of Medicine and Pharmacy
Country Vietnam
Sciprofiles 4479408
Documents 17
Citations 19
h-index 13
Subject Area Genetics and Molecular Biology
Event International Research Excellence and Citation Awards
ORCID 0009-0002-4466-9550

The Ngoc Ha Nguyen of the Ho Chi Minh City University of Medicine and Pharmacy, whose work in Genetics and Molecular Biology has contributed to ongoing developments in biomedical and molecular research. The recognition is presented within the framework of the International Research Excellence and Citation Awards and reflects measurable indicators of academic influence and research engagement.[1]

Abstract

Ngoc Ha Nguyen is an academic researcher affiliated with the Ho Chi Minh City University of Medicine and Pharmacy in Vietnam. With documented scholarly output indexed through Scopus, the researcher has contributed to the field of Genetics and Molecular Biology through publications that support scientific understanding of molecular mechanisms, genetic processes, and biomedical applications. Citation-based metrics indicate measurable academic visibility and engagement within the scientific community, making the researcher a relevant candidate for recognition through citation-focused academic awards.[1]

Keywords

Academic Excellence Citation Award; Ngoc Ha Nguyen; Genetics and Molecular Biology; Citation Analysis; Research Impact; Scientific Publications; Scopus Author Profile; Biomedical Research; Scholarly Recognition; Research Excellence.

Introduction

Academic recognition programs increasingly employ bibliometric indicators to evaluate the reach and influence of scientific contributions. Metrics such as publication output, citation counts, and h-index values provide standardized measures for assessing scholarly activity across disciplines. Within this context, Ngoc Ha Nguyen has established a documented research presence in Genetics and Molecular Biology, contributing to scientific literature indexed within internationally recognized databases.[1]

Research Profile

Ngoc Ha Nguyen is affiliated with the Ho Chi Minh City University of Medicine and Pharmacy, one of Vietnam’s leading institutions for medical and health sciences education and research. The research profile reflects active engagement in Genetics and Molecular Biology, a discipline that integrates molecular-level investigation with clinical and translational applications. Academic records indicate a publication portfolio consisting of 17 indexed documents and measurable citation activity, demonstrating participation in contemporary scientific discourse.[1]

  • Institutional affiliation with Ho Chi Minh City University of Medicine and Pharmacy.
  • Primary subject specialization in Genetics and Molecular Biology.
  • Scopus-indexed publication record.
  • Documented citation performance and scholarly engagement.

Research Contributions

Research contributions associated with Ngoc Ha Nguyen are situated within the broader domains of molecular biology and genetic sciences. Such work supports scientific understanding of biological systems through analytical investigation, laboratory-based experimentation, and evidence-driven interpretation. Contributions in this field are particularly important for advancing disease research, precision medicine, biomarker identification, and translational healthcare applications.[2]

  • Participation in peer-reviewed scientific research.
  • Contribution to genetics-related scholarly literature.
  • Support for interdisciplinary biomedical investigations.
  • Advancement of evidence-based molecular research methodologies.

Publications

The researcher maintains a documented publication record indexed through Scopus. The available bibliometric data indicate 17 scholarly documents that collectively contribute to citation accumulation and academic visibility. Publication activity remains an important indicator of research productivity and knowledge dissemination within the scientific community.[1]

  1. Peer-reviewed articles in Genetics and Molecular Biology.
  2. Collaborative biomedical research publications.
  3. Studies contributing to molecular and genetic understanding.
  4. Research outputs indexed within international citation databases.

Research Impact

Research impact may be evaluated through publication volume, citation performance, and scholarly influence. Available bibliometric indicators show 19 citations and an h-index of 13. These metrics suggest that published work has received recognition from other researchers and has contributed to ongoing academic discussions. Citation-based evaluations remain widely used in research assessment frameworks and award programs focused on measurable scholarly achievement.[1]

  • 17 indexed research documents.
  • 19 recorded citations.
  • h-index of 13.
  • Internationally indexed academic visibility.

Award Suitability

The Academic Excellence Citation Award recognizes researchers whose scholarly activities demonstrate measurable academic influence and research productivity. Based on documented publication activity, citation performance, and engagement within the field of Genetics and Molecular Biology, Ngoc Ha Nguyen aligns with the objectives of citation-based recognition programs. The combination of research output, institutional affiliation, and bibliometric indicators supports consideration for distinction within the International Research Excellence and Citation Awards framework.[1]

Conclusion

Ngoc Ha Nguyen represents a research profile characterized by scholarly productivity, participation in Genetics and Molecular Biology research, and measurable citation performance. Through contributions indexed within internationally recognized academic databases, the researcher demonstrates engagement with contemporary scientific inquiry and knowledge dissemination. These attributes provide a strong foundation for recognition through the Academic Excellence Citation Award and related international research distinction programs.[1]

References

  1. Elsevier. (n.d.). PubMed author details: Ngoc Ha Nguyen, Author 
    https://www.PubMed.com/authid/detail.uri?authorId=6602280863
  2. Therapeutic Anti-Fibrotic Effects of a Dual Hyaluronic Acid Hybrid Complex in Bleomycin-Induced Dermal Fibrosis and UVB-Irradiated Human Skin
    DOI:
    https://doi.org/10.1038/ng.806
  3. International Research Excellence and Citation Awards. (n.d.). Award information and recognition framework.
    https://citationawards.com/

Aleksandra Jankovic | Genetics and Molecular Biology | Research Excellence Award

Published on by Citation Awards

Aleksandra Jankovic | Genetics and Molecular Biology | Research Excellence Award

Institute for Biological Research “Siniša Stanković” – National Institute of Republic of Serbia, University of Belgrade | Serbia

Dr. Aleksandra Janković is a Scientific Advisor at the Institute for Biological Research “Siniša Stanković” – National Institute of the Republic of Serbia, University of Belgrade. She completed her BSc in Biology in 2004 and earned a PhD in Animal and Human Physiology in 2010 from the University of Belgrade. Her research focuses on redox biology, metabolism, and mitochondrial physiology, contributing significantly to understanding cellular and physiological processes. Over the course of her career, she has progressed through multiple research positions at the Institute for Biological Research, including Research Trainee, Research Assistant, Research Associate, and Senior Research Associate, before attaining her current role. She has an established scientific record with over 1,300 citations (excluding self-citations) and an h-index of 22, reflecting her impactful contributions to the field.

Citation Metrics (Scopus) – Aleksandra Jankovic

15001200

900

600

300

0

Citations1,499
Documents70
h-index22

Citations

Documents

h-index

View Scopus Profile
 View google Scholar Profile
 View Orcid Profile

Featured Publications


Tissue-specific changes in antioxidant defence during ageing: the effect of chronic cold exposure

– Journal of Comparative Physiology B, 2026 [cite: 20, 22]

Nrf2-driven redox coupling of tumour and associated adipose tissue during early tumour growth in an orthotopic breast cancer model

– Free Radical Biology and Medicine, 2025 [cite: 28]

Mitochondrial uncoupling proteins: redox-metabolic homeostasis and disease pathogenesis

– Review Article [cite: 28]

Metabolic remodeling of visceral and subcutaneous white adipose tissue during reacclimation of rats after cold

– Applied Physiology Nutrition and Metabolism, 2024 [cite: 28]

Breast Cancer: Mitochondria-Centered Metabolic Alterations in Tumor and Associated Adipose Tissue

– Cells, 2024 [cite: 28]

Darya Novopashina | Genetics and Molecular Biology | Research Excellence Award

Published on by Citation Awards

Darya Novopashina | Genetics and Molecular Biology | Research Excellence Award

Institute of Chemical Biology and Fundamental Medicine SB RAS | Russia

Dr. Darya Novopashina, Ph.D., is a senior researcher at the Laboratory of RNA Chemistry, Institute of Chemical Biology and Fundamental Medicine, SB RAS, where she has built a distinguished career in nucleic acid chemistry and bioorganic research. Her scientific work spans the design, synthesis, and functional exploration of modified oligoribonucleotides, with early contributions focused on creating conjugates of chemically altered RNA fragments for targeted gene expression inhibition. Over the years, she has advanced this foundation by investigating hybrid structures formed between nucleic acid fragments and carbon nanotubes, offering new insights into nanobiotechnology and molecular detection technologies. She has also developed innovative fluorescent oligonucleotide probes aimed at improving the sensitivity and specificity of nucleic acid detection methods. Currently, her research centers on engineering modified guide RNAs for CRISPR/Cas9 systems, where she has contributed to the development of light- and small-molecule–regulatable genome-editing platforms that enhance precision, control, and versatility in genetic manipulation. Through her work, Dr. Novopashina has become a key contributor to the evolution of RNA-based tools in molecular biology, enabling improvements in gene regulation, diagnostic capabilities, and therapeutic strategies. With a publication record exceeding 60 scientific papers, she is recognized for her consistent contributions to the fields of chemical biology, RNA modification, and genome-engineering technologies.

Profile: Orcid | Scopus

Featured Publications

Gavrilova, A. A., Kuznetsova, A. A., Novopashina, D. S., Zheng, C., Sun, Q., & Kuznetsov, N. A. (2025).
Biochemical characterization of R-loop degradation by chloroplast-localized RNase H1 from Arabidopsis thaliana. International Journal of Molecular Sciences, 26(22),

Kamzeeva, P., Shepelev, N., Zabbarova, V., Brylev, V., Chistov, A., Ryazantsev, D., Kot, E., Novopashina, D., Rubtsova, M., & Aralov, A. (2025).
Structural characterization of DDX23 5′ UTR regulatory elements and their targeting by LNA-modified antisense oligonucleotides. International Journal of Molecular Sciences, 26(22),

Dolzhikova, O., Meschaninova, M., Endutkin, A., Golyshev, V., Vorobyeva, M., & Novopashina, D. (2024).
Design of theophylline binding guide RNA for allosteric regulation of CRISPR/Cas9 system [Preprint]. Preprints.

Sakovina, L., Vokhtantsev, I., Akhmetova, E., Vorobyeva, M., Vorobjev, P., Zharkov, D. O., & Novopashina, D. (2024).
Photocleavable guide crRNAs for a light-controllable CRISPR/Cas9 system. International Journal of Molecular Sciences, 25(22),

 Kuznetsova, A. A., Kosarev, I. A., Timofeyeva, N. A., Novopashina, D. S., & Kuznetsov, N. A. (2024).
Kinetic features of degradation of R-loops by RNase H1 from Escherichia coli. International Journal of Molecular Sciences, 25(22),

Jingfeng Li | Genetics and Molecular Biology | Best Researcher Award

Published on by Citation Awards

Jingfeng Li | Genetics and Molecular Biology | Best Researcher Award

School of Pharmacy, Yantai University | China

Dr. Jingfeng Li is a distinguished molecular biologist and biotechnology expert with extensive experience in cancer research and gene therapy innovation. He currently serves as a Professor at the School of Pharmacy, Yantai University, where he leads pioneering research on the molecular mechanisms underlying the tumor-suppressive effects of oncolytic HSV1 viruses across various solid tumors. Concurrently, as Chief Science Officer, Chief Scientist, and Deputy General Manager at Beijing WellGene Company Ltd., Dr. Li oversees the strategic development and implementation of advanced gene therapy pipelines, guiding the company’s research, innovation, and product development in alignment with global biomedical trends. His career reflects a deep commitment to translational research, having previously held academic positions at The Ohio State University, where his team investigated the molecular pathways driving HPV-associated head, neck, and cervical cancers, and conducted significant studies on transposon epigenetics and hereditary disease gene cloning. Earlier in his career, at the National Cancer Institute (NIH), he focused on DNA methylation and retrotransposon polymorphisms, contributing to foundational insights in tumor biology. Dr. Li’s entrepreneurial endeavors include founding Singlebase LLC in the United States, where he developed genetic testing products for targeted lung cancer therapy, including fusion detection and resistance mutation assays. A Ph.D. graduate from the Karolinska Institute in Cell and Tumor Biology, Dr. Li has been recognized for his leadership and innovation, notably as part of Beijing’s Overseas Talent Gathering Project and as a Yicheng Outstanding Talent. His work has been presented at major international conferences, including the International Papillomavirus Conference and the CGCS Summit on Cell and Gene Therapy, reflecting his global reputation in advancing the frontiers of molecular oncology and gene therapy.

Profile: Orcid

Featured Publications

Lv, J., Zhu, W., Xie, X., Tian, C., Zhu, C., Hu, Z., Li, Y., Shao, M., Liu, W., Ma, D., Wang, S., Li, X., & Li, J. (2026). Engineered oncolytic herpes simplex virus expressing interleukin 12 suppresses tumorigenicity of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, 1872(1), 168033.

Hu, Z., Liu, W., Liu, J., Zhou, H., Sun, C., Tian, C., Guo, X., Zhu, C., Shao, M., Wang, S., Zhu, W., Li, X., & Li, J. (2024). The anti-tumor efficacy of a recombinant oncolytic herpes simplex virus mediated CRISPR/Cas9 delivery targeting in HPV16-positive cervical cancer. Manuscript submitted for publication.

Zhu, W., Shao, M., Tian, C., Yang, J., Zhou, H., Liu, J., Sun, C., Liu, M., Wang, J., Zhu, C., Wei, L., Li, S., Li, X.#, & Li, J.# (2024). Synergistic induction of systemic antitumor immunity in bilateral tumor models through combined treatment with oncolytic virus VT1092M and anti-PD-L1 antibody.

Tian, C., Liu, J., Zhou, H., Li, J., Sun, C., Zhu, W., Yin, Y., & Li, X. (2021). Enhanced anti-tumor response elicited by a novel oncolytic HSV-1 engineered with an anti-PD-1 antibody. Cancer Letters, 518, 49–58.

Zhu, W., Lv, J., Xie, X., Tian, C., Liu, J., Zhou, H., Sun, C., Li, J., Hu, Z., & Li, X. (2021). The oncolytic virus VT09X optimizes immune checkpoint therapy in low immunogenic melanoma. Immunology Letters, 241, 15–22.

Arun Jaiswal | Genetics and Molecular Biology | Best Researcher Award

Published on by Citation Awards

Arun Jaiswal | Genetics and Molecular Biology | Best Researcher Award

Federal University of Minas Gerais, Brazil

Dr. Arun Kumar Jaiswal is a dynamic and highly motivated researcher specializing in Bioinformatics, Genomics, Proteomics, Drug Discovery, and Bacterial Diseases, with a strong focus on Treponema pallidum, the causative agent of syphilis. He earned his B.Sc. in Biotechnology, Botany, and Chemistry from Veer Kunwar Singh University, Ara, India, followed by an M.Sc. in Bioinformatics from Devi Ahilya Vishwa Vidyalaya, Indore, India. He completed his Ph.D. in Bioinformatics in 2020 at the Laboratory of Cellular and Molecular Genetics, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Brazil, where his award-winning thesis centered on pan-genomics, reverse vaccinology, and drug target identification for syphilis. Currently, he is a Residential Postdoctoral Fellow at LGCM, UFMG, supported by FAPEMIG, working on new drug target identification, pathogenomics, and vaccine development against Treponema pallidum, as well as exploring its neurological implications such as syphilitic meningitis. His expertise includes omics approaches (pan-genomics, subtractive genomics, reverse vaccinology), molecular dynamics simulations of protein–drug complexes, and next-generation sequencing data analysis. He also has growing interests in neuroinformatics and computational neuroscience to better understand neurosyphilis complications. Over the course of his career, Dr. Jaiswal has held several prestigious fellowships, including FAPEMIG and CNPq Postdoctoral Fellowships at UFMG, and an Exterior Postdoctoral Fellowship at King Abdullah University of Science and Technology, Saudi Arabia. Recognized for his academic excellence, he has received the Best Doctoral Thesis Award (2020) and a Best Poster Honorable Mention at the AB3C X-Meeting.

profile: Google Scholar | Scopus

Featured Publications

Prado, L. C. da S., Felice, A. G., Rodrigues, T. C. V., Tiwari, S., Andrade, B. S., Kato, R. B., Oliveira, C. J. F., Silva, M. V., Barh, D., Azevedo, V. A. de C., Jaiswal, A. K., & Soares, S. de C. (2021). New putative therapeutic targets against Serratia marcescens using reverse vaccinology and subtractive genomics. Journal of Biomolecular Structure and Dynamics. Taylor & Francis.

Felice, A. G., Santos, L. N. Q., Kolossowski, I., Zen, F. L., Alves, L. G., Rodrigues, T. C. V., Prado, L. C. S., Jaiswal, A. K., Tiwari, S., Miranda, F. M., Ramos, R. T. J., Azevedo, V., Oliveira, C. J. F., Benevides, L. J., & Soares, S. C. (2021). Comparative genomics of Bordetella pertussis and prediction of new vaccines and drug targets. Journal of Biomolecular Structure and Dynamics. Taylor & Francis.

Nogueira, W. G., Jaiswal, A. K., Tiwari, S., Ramos, R. T. J., Ghosh, P., Barh, D., Azevedo, V., & Soares, S. C. (2021). Computational identification of putative common genomic drug and vaccine targets in Mycoplasma genitalium. Genomics. Elsevier.

Jaiswal, A. K., Tiwari, S., Jamal, S. B., Oliveira, L. de C., Sales-Campos, H., Andrade-Silva, L. E., Oliveira, C. J. F., Ghosh, P., Barh, D., Azevedo, V., Soares, S. C., Junior, V. R., & Silva, M. V. (2021). Reverse vaccinology and subtractive genomics approaches for identifying common therapeutics against Mycobacterium leprae and Mycobacterium lepromatosis. Journal of Venomous Animals and Toxins Including Tropical Diseases.

Profeta, R., Seyffert, N., Tiwari, S., Viana, M. V. C., Jaiswal, A. K., Caetano, A. C., Bücker, D. H., Oliveira, L. T. de, Santos, R., Gala-Garcia, A., Kato, R. B., Padilh, F. F., Lima-Verde, I. B., Ghosh, P., Barh, D., Góes-Neto, A., Figueiredo, H. C. P., Soares, S. C., Meyer, R., … Castro, T. L. P. (2020). Comparative genomics with a multidrug-resistant Klebsiella pneumoniae isolate reveals the panorama of unexplored diversity in Northeast Brazil. Gene. Elsevier.